 |
|
Robotic assisted kidney cancer surgery proves to be beneficial to patients
April 27, 2009Fox Chase Cancer Center researchers find that outcomes of robotic assisted kidney cancer surgery, when performed by experienced surgeons at high volume centers, prove more beneficial to patients when compared to open surgery. The study, authored by Fox Chase robotic surgeon Rosalia Viterbo, MD, was presented today at the American Urological Association's Annual Meeting,
The standard treatment for kidney cancer is to surgically remove the entire or a portion of the kidney. This is known as nephron-sparing surgery, or partial nephrectomy, and is commonly performed using traditional open surgery. Recently, there has been interest in applying a laparoscopic approach for this procedure, however it has proven to be technically challenging to many surgeons.
Experienced laparoscopic surgeons at high volume centers, such as Fox Chase, are now using the da Vinci® robot assisted surgical system for patients with kidney cancer, or renal cell carcinoma. The advanced technology has enabled faster and greater technical proficiency allowing for completion of complex surgical procedures, facilitating a minimally invasive approach for partial nephrectomy.
"Our patients have experienced many benefits from the robot assisted approach, including shorter hospital stays (average 3 days), preserved kidney function (reduced need for dialysis), smaller scars with optimal cosmetic results, lower blood loss and easier and earlier return to normal activity," says Viterbo.
As a result of the fast recovery, patients do not delay the next step in their treatment plan, chemotherapy or radiation therapy, stopping the disease from progressing as fast. Similarly, patients with disease on both kidneys benefit because there is less waiting time between surgeries and there is no delay on further treatment. Again, this provides less opportunity for the cancer to grow and spread.
William Krassan came to Fox Chase after learning he had renal cell carcinoma in the right kidney and cystic renal cell carcinoma in the left. Using the da Vinci robot, Viterbo performed a partial nephrectomy on each kidney, just 8 weeks apart. This laparoscopic approach allowed the surgeon to reach the kidney through 4 tiny holes in the patient's abdomen. Open surgery would have required one large incision in his back and a longer time until the next surgery could have occurred.
"The procedure and recovery were fairly painless and easy," says Krassan. Dr. Viterbo did a wonderful job in an expeditious way. She was able to save 90 percent of my right kidney and two-thirds of my left kidney."
Viterbo added, "Results of the study show robot assisted partial nephrectomy to be a safe and technically feasible minimally invasive approach to kidney sparing surgery."
Fox Chase Cancer Center
"Our patients have experienced many benefits from the robot assisted approach, including shorter hospital stays (average 3 days), preserved kidney function (reduced need for dialysis), smaller scars with optimal cosmetic results, lower blood loss and easier and earlier return to normal activity," says Viterbo.
As a result of the fast recovery, patients do not delay the next step in their treatment plan, chemotherapy or radiation therapy, stopping the disease from progressing as fast. Similarly, patients with disease on both kidneys benefit because there is less waiting time between surgeries and there is no delay on further treatment. Again, this provides less opportunity for the cancer to grow and spread.
William Krassan came to Fox Chase after learning he had renal cell carcinoma in the right kidney and cystic renal cell carcinoma in the left. Using the da Vinci robot, Viterbo performed a partial nephrectomy on each kidney, just 8 weeks apart. This laparoscopic approach allowed the surgeon to reach the kidney through 4 tiny holes in the patient's abdomen. Open surgery would have required one large incision in his back and a longer time until the next surgery could have occurred.
"The procedure and recovery were fairly painless and easy," says Krassan. Dr. Viterbo did a wonderful job in an expeditious way. She was able to save 90 percent of my right kidney and two-thirds of my left kidney."
Viterbo added, "Results of the study show robot assisted partial nephrectomy to be a safe and technically feasible minimally invasive approach to kidney sparing surgery."
Fox Chase Cancer Center
Kidney Cancer Current Events and Kidney Cancer News RSSNew data: Hospital imaging centers poised to pull back, hitting patients hardest in rural areas
Survivors and patients with cancers and heart disease, along with patient advocate organizations and physicians, today urged policymakers to enhance early diagnosis of deadly diseases by preserving access to advanced imaging, such as MRI and CT scans, in final health care reform legislation.
Stem cell protein offers a new cancer target
A protein abundant in embryonic stem cells is now shown to be important in cancer, and offers a possible new target for drug development, report researchers from the Stem Cell Program at Children's Hospital Boston.
2-drug combination appears safe and active in metastatic kidney cancer
Fox Chase Cancer Center investigators report that a two-drug blockade of mTOR signaling appears safe in metastatic kidney cancer in a phase I trial.
Finding Will Improve Accuracy of Cancer Diagnosis
Van Andel Research Institute (VARI) investigators working in collaboration with Cleveland Clinic researchers have determined that two types of kidney tumors previously thought to be different diseases are actually variations of the same disease.
Does a person's insurance coverage affect their access to quality cancer care?
Does a person's insurance coverage affect their access to quality cancer care? According to researchers at Fox Chase Cancer Center, insurance coverage may not only affect a patient's access to health care, but also the quality of care they receive.
Getting down to cancer basics
Researchers have identified a new cancer gene - one that is common to many cancers and affects the most basic regulation of our genes. The new example - a gene on the X chromosome called UTX - is found in 10% of cases of multiple myeloma and 8% of esophageal cancers.
Castrate resistant prostate cancer: New therapeutic approaches
Today Dr. Martin Gleave of the Vancouver Prostate Centre in Canada gave a lecture about new approaches to treat castrate-resistant prostate cancer (CRCP) during the 24th Annual Congress of the European Association of Urology in Stockholm, Sweden.
Freezing kidney cancer: Hot treatment should be new gold standard for destroying small tumors
Freezing kidney tumors-using a safe minimally invasive interventional radiology treatment that kills the cancer 100 percent effectively without surgery-should be the gold standard or first treatment option for all individuals with tumors that are 4 centimeters in size or smaller. And, this treatment-interventional cryoablation-is a viable option for people with larger tumors, according to two studies presented at the Society of Interventional Radiology's 34th Annual Scientific Meeting.
Roadkill study could speed detection of kidney cancer
Large-scale data mining of gene networks in fruit flies has led researchers to a sensitive and specific diagnostic biomarker for human renal cell carcinoma, the most common type of kidney cancer.
Research suggests doctors should consider kidney-sparing surgery
A study of almost 1,500 kidney cancer patients treated at Memorial Sloan Kettering Cancer Center suggests that surgery to spare as much kidney tissue as possible may improve overall survival in patients who also have reduced kidney function at the time their cancer is diagnosed.
More Kidney Cancer Current Events and Kidney Cancer News Articles
 |
100 Questions & Answers About Kidney Cancer (100 Questions & Answers about) by Steven C. Campbell (Author) There are 37,000 cases of kidney (renal cell) cancer in the US and 13,000 related deaths annually. 100 Questions and Answers About Kidney Cancer explains all aspects of the disease resulting in full awareness of what to expect when battling kidney cancer. |
 |
Johns Hopkins Patients' Guide to Kidney Cancer by Michael A. Carducci (Author) Johns Hopkins Patients' Guide to Kidney Cancer is a concise how to guide that puts you on a path to wellness by explaining kidney cancer treatment. It guides you through the maze of treatment decisions, simplifies the schedule, and performs the task of putting together your plan of care in layman's terms. Empower yourself with accurate, understandable information that will give you the ability to confidently participate in the decision making about your treatment. |
 |
Nothing to Fear by Larry Burkett (Author) In Nothing to Fear, Larry Burkett tells his personal journey of a seven-year battle with cancer. Filled with intimate stories and wisdom from the Word, this book will be a great help to the thousands of people who fight this disease, or to friends and loved ones of those in the midst of the struggle. Larry's 2003 passing was the result of heart failure rather than cancer. His legacy continues today and his words still bring hope to those in need of encouragement. 'Even if you can avoid dying from cancer, you'll certainly face something else that will eventually kill you, because all of us are going to die. As god as modern medicine is, it is not the ultimate answer. It will let you down. Trusting God is the answer. He will never let you down.' -Excerpt from Nothing to Fear |
 |
Carcinoma of the Kidney (Contemporary Issues in Cancer Imaging) by Uday Patel (Editor) The last two decades have seen ground-shifting changes in the epidemiology, genetics, diagnosis and management of renal cancer. Advances in diagnosis have led to many tumours being identified at an asymptomatic stage. There have also been parallel advances in treatment, such as nephron sparing procedures and radiologically guided ablative procedures. However, these changes have brought with them dilemmas such as our ability to evaluate the nature and aggressiveness of early stage tumours and how best to identify those patients who will benefit most from early treatment. This practical, clinically-oriented volume focuses on these current diagnostic and clinical challenges, making it relevant to all members of the multidisciplinary cancer care team. |
 |
Dx/ Rx: Genitourinary Oncology: Cancer of the Kidney, Bladder, and Testis (Dx/Rx Oncology) by Matthew Galsky (Author) Designed for both oncologists and urologists, Dx/Rx: Genitourinary Oncology is a current, concise, quick reference guide to the diagnosis and therapy of cancers of the bladder/urothelial tract, kidneys, and testis. Tightly organized into a super-condensed outline-bulleted format, this handy, pocket-sized manual details precise, up-to-date information on the epidemiology, classification, diagnosis, treatment, and risk factors of genitourinary disorders. Throughout the book, tables and figures summarize important clinical data and current professional society recommendations, while salient references direct readers to additional information. |
 |
Kidney Cancer: A New Approach Most people have two functional kidneys which help regulate electrolytes such as sodium, potassium, calcium, and magnesium. Kidney tumors may change these important functions and can lead to a diagnosis of kidney cancer. On this program we spend time with courageous patients who are coping with their kidney cancer by seeking a new approach. Kidney Cancer is part of the award winning public television series Healthy Body, Healthy Mind. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply. |
 |
Kidney Cancer (Cancer Treatment and Research) by Robert A. Figlin (Editor) Kidney cancer is a heterogenous disease. This book covers: + new surgical approaches which are becoming the standard, i.e., nephon sparing, laporascopic, minimally invasive techniques; + new staging and prognostic capabilities; + evolving therapeutic options include, cell based vaccine, gene and antibody therapy; + molecular genetics allow for a better understanding of the various types of kidney cancer. Kidney Cancer is a comprehensive review covering present and future surgical approaches, staging and prognostic factors, currently accepted and future plans for prevention, diagnosis and treatment. Contributing authors to this book are internationally recognized specialists in this disease. This book will be useful to the specialist (oncologist and... |
 |
Understanding Kidney Cancer Anatomical Chart by Anatomical Chart Company (Producer) Understanding Kidney Cancer describes the role of the kidneys and defines kidney cancer. The chart shows a cross-section of the kidney and adrenal gland and illustrates the kidneys and surrounding veins and arteries in the context of body. It illustrates and describes the stages I through IV of kidney cancer, lists risk factors and signs and symptoms, describes diagnostic tests and treatments options and suggests ways to help prevent kidney cancer. |
 |
Kidney Cancer Awareness Ribbon Mouse Pad by MyHeritageWear.com The Kidney Cancer Ribbon proudly displayed on a mouse pad. There is no better way to achieve awareness for the meaning of the Kidney Cancer Ribbon than to display it on your mouse pad for everyone to see. The mouse pad measures at 9.25 x 7.75, it is machine washable, and the colors will not fade or run. Start gaining awareness today by presenting your Kidney Cancer Ribbon mouse pad at work or at home. It is certain to keep your mouse rolling in style all while gaining support and awareness! |
 |
Anatomical Human Diseased Kidney Cancer Model by GPI This oversized 2-sided kidney model has a nomal anatomy cutaway on one side and a diseased anatomy cutaway on the other side depicting: infection, scarring, atrophy, urinary (kidney) stones, tumor, polycystic disease, hypertension effects. Size: 3 3/4" x 2 1/2" x 6 1/2" Includes stand and detailed instructional card. Ideal for clinical display and consumer education. |
| © 2009 BrightSurf.com |